{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:28:30Z","timestamp":1770222510745,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2624,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1111\/jth.13114","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T10:02:11Z","timestamp":1439460131000},"page":"1787-1789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure"],"prefix":"10.1016","volume":"13","author":[{"given":"K.","family":"Donohoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13114_bb0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-2143(99)90062-8","article-title":"Clinical and laboratory manifestations of anti\u2010factor V antibodies","volume":"133","author":"Ortel","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.13114_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V60.1.59.59","article-title":"Radioimmunoassay of factor V in human plasma and platelets","volume":"60","author":"Tracy","year":"1982","journal-title":"Blood"},{"key":"10.1111\/jth.13114_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1537-2995.2002.00011.x","article-title":"Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure","volume":"42","author":"Streiff","year":"2002","journal-title":"Transfusion"},{"key":"10.1111\/jth.13114_bb0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11239-010-0529-6","article-title":"Acquired factor V inhibitors: a systematic review","volume":"31","author":"Franchini","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13114_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00001721-200412000-00003","article-title":"Factor V inhibitors: rare or not so uncommon? A Multi\u2010Laboratory Investigation","volume":"8","author":"Favaloro","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13114_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1160\/TH08-11-0767","article-title":"Acquired factor V inhibitor. A problem\u2010based systematic review","volume":"101","author":"Ang","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13114_bb0040","doi-asserted-by":"crossref","first-page":"E221","DOI":"10.1097\/01.BRS.0000065491.60871.06","article-title":"Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases","volume":"28","author":"Poynton","year":"2003","journal-title":"Spine"},{"key":"10.1111\/jth.13114_bb0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3171\/jns.1993.78.5.0817","article-title":"Bovine thrombin\u2010induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients","volume":"78","author":"Spero","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1111\/jth.13114_bb0050","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood.V76.10.2011.2011","article-title":"Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin","volume":"76","author":"Zehnder","year":"1990","journal-title":"Blood"},{"key":"10.1111\/jth.13114_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000658-200101000-00014","article-title":"Immunological impact and clinical outcomes after surgical exposure to bovine thrombin","volume":"233","author":"Ortel","year":"2001","journal-title":"Ann Surg"},{"key":"10.1111\/jth.13114_bb0060","first-page":"593","article-title":"Clinical use of topical thrombin as a surgical hemostat","volume":"2","author":"Lew","year":"2008","journal-title":"Biologics"},{"key":"10.1111\/jth.13114_bb0065","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1055\/s-2003-39678","article-title":"Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer","volume":"35","author":"Caers","year":"2003","journal-title":"Endoscopy"},{"key":"10.1111\/jth.13114_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-010018","article-title":"Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone","author":"Khalafallah","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1111\/jth.13114_bb0075","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.22073","article-title":"Acquired factor V inhibitor complicating warfarin therapy","volume":"86","author":"Gartrell","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13114_bb0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V56.5.835.835","article-title":"Successful management of bleeding in a patient with factor V inhibitor by platelet transfusion","volume":"56","author":"Chediak","year":"1980","journal-title":"Blood"},{"key":"10.1111\/jth.13114_bb0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0950-3536(98)80050-4","article-title":"Acquired factor V inhibitors","volume":"11","author":"Kn\u00f6bl","year":"1998","journal-title":"Baillieres Clin Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13114","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13114","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622084239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622084239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13114\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:08:32Z","timestamp":1761534512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622084239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1538783622084239"],"URL":"https:\/\/doi.org\/10.1111\/jth.13114","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}